We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSAK icon
4976
PUT
Lesaka Technologies
LSAK
$406M
$710K ﹤0.01%
59,700
+49,600
+491% +$503K
NGD
4977
PUT
DELISTED
New Gold Inc
NGD
$710K ﹤0.01%
215,900
+57,700
+36% +$194K
ARNA
4978
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$710K ﹤0.01%
20,900
-9,700
-32% -$276K
AIN icon
4979
Albany International
AIN
$1.84B
$709K ﹤0.01%
11,543
+1,926
+20% +$116K
BCO icon
4980
Brink's
BCO
$4.71B
$709K ﹤0.01%
9,014
-2,297
-20% -$186K
KRO icon
4981
CALL
KRONOS Worldwide
KRO
$975M
$709K ﹤0.01%
+27,500
New +$720K
NTCT icon
4982
PUT
NETSCOUT
NTCT
$2.88B
$709K ﹤0.01%
+23,300
New +$712K
SDY icon
4983
CALL
State Street SPDR S&P Dividend ETF
SDY
$22.2B
$709K ﹤0.01%
7,500
+500
+7% +$46.9K
CHIC
4984
DELISTED
Global X MSCI China Communication Services ETF
CHIC
$709K ﹤0.01%
+22,940
New +$695K
CHGG icon
4985
Chegg
CHGG
$87.5M
$708K ﹤0.01%
43,339
-15,466
-26% -$236K
EMB icon
4986
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$708K ﹤0.01%
6,100
+1,100
+22% +$127K
OLLI icon
4987
PUT
Ollie's Bargain Outlet
OLLI
$4.62B
$708K ﹤0.01%
13,300
+4,300
+48% +$203K
TMF icon
4988
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.12B
$708K ﹤0.01%
3,203
-1,619
-34% -$346K
FTV icon
4989
Fortive
FTV
$18.6B
$707K ﹤0.01%
15,491
+861
+6% +$39.4K
FUTY icon
4990
Fidelity MSCI Utilities Index ETF
FUTY
$2.33B
$707K ﹤0.01%
+20,481
New +$732K
TREX icon
4991
Trex
TREX
$5.06B
$706K ﹤0.01%
+26,072
New +$664K
EMWP
4992
DELISTED
Eros Media World PLC
EMWP
$706K ﹤0.01%
+3,661
New +$902K
CO
4993
DELISTED
Global Cord Blood Corporation
CO
$706K ﹤0.01%
+70,983
New +$776K
AVT icon
4994
CALL
Avnet
AVT
$7.86B
$705K ﹤0.01%
17,800
+7,900
+80% +$316K
DXJ icon
4995
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
$705K ﹤0.01%
11,878
-35,631
-75% -$2.06M
GLL icon
4996
PUT
ProShares UltraShort Gold
GLL
$104M
$705K ﹤0.01%
2,550
+1,600
+168% +$461K
IMTM icon
4997
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
$705K ﹤0.01%
+23,095
New +$704K
RBC icon
4998
RBC Bearings
RBC
$17.7B
$705K ﹤0.01%
+5,581
New +$700K
AORT icon
4999
Artivion
AORT
$1.42B
$704K ﹤0.01%
+36,747
New +$736K
SGYP
5000
PUT
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$703K ﹤0.01%
315,200
+200,000
+174% +$497K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.